Patients with pathogenic KDM5A mutations present with a spectrum of neurodevelopmental phenotypes including autism spectrum disorder, intellectual disability, and developmental delay. In addition, the majority have absent speech, and very few have severely impaired speech. Other observed phenotypes include seizures, motor impairment, and muscle hypotonia.
KDM5A